Position in LH
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$500,001
+$29,852 QoQ
Shares Held
1,874
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Johnson Financial Group, Inc. holds $1,960,047 across 8 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
1,437 | $756,494 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,487 | $745,522 | |
| 3 | DHR |
Danaher Corp /De/
|
1,742 | $331,816 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
304 | $58,738 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
51 | $27,009 | |
| 6 | DGX |
Quest Diagnostics Inc
|
89 | $18,863 | |
| 7 | NTRA |
Natera, Inc.
|
61 | $16,558 | |
| 8 | A |
Agilent Technologies, Inc.
|
38 | $5,047 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $500,001 | 1,874 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $470,149 | 1,874 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $593,926 | 2,069 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $11,287 | 43 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $451,282 | 1,939 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,860 | 43 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $730,108 | 3,267 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $390,127 | 1,917 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||